Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study
- PMID: 22865498
- PMCID: PMC3653417
- DOI: 10.1007/s12160-012-9393-2
Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study
Abstract
Background: Omega-3 fatty acids reduced heart rate (HR) and blood pressure (BP) in some studies, but dose-response studies are rare, and little is known about underlying mechanisms.
Purpose: We examined effects of 0.85 g/day eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) (low dose) and 3.4 g/day EPA + DHA (high dose) on HR and systemic hemodynamics during rest, speech, and foot cold pressor tasks.
Methods: This was a dose-response, placebo-controlled, double-blind, randomized, crossover trial (8-week treatment, 6-week washout) in 26 adults.
Results: Throughout the testing sessions, HR was reduced in a dose-dependent manner. The high dose reduced BP and stroke volume and increased pre-ejection period. Reductions in BP were associated with increases in erythrocyte omega-3 fatty acids.
Conclusions: High-dose long-chain omega-3 fatty acids can reduce BP and HR, at rest and during stress. These findings suggest that at-risk populations may achieve benefits with increased omega-3 intake. The trial was registered on ClinicalTrials.gov (NCT00504309).
Figures


Comment in
-
Discerning whether and how long-chain, n-3 fatty acids lower blood pressure: a comment on Skulas-Ray et al.Ann Behav Med. 2012 Dec;44(3):295-6. doi: 10.1007/s12160-012-9407-0. Ann Behav Med. 2012. PMID: 22918613 No abstract available.
Similar articles
-
Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia.Psychosom Med. 2013 May;75(4):382-9. doi: 10.1097/PSY.0b013e318290a107. Epub 2013 Apr 16. Psychosom Med. 2013. PMID: 23592752 Free PMC article. Clinical Trial.
-
Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.Hypertension. 1999 Aug;34(2):253-60. doi: 10.1161/01.hyp.34.2.253. Hypertension. 1999. PMID: 10454450 Clinical Trial.
-
Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women.Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H873-H881. doi: 10.1152/ajpheart.00677.2018. Epub 2019 Feb 8. Am J Physiol Heart Circ Physiol. 2019. PMID: 30735073 Clinical Trial.
-
A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels.Vasc Health Risk Manag. 2006;2(3):251-62. doi: 10.2147/vhrm.2006.2.3.251. Vasc Health Risk Manag. 2006. PMID: 17326331 Free PMC article. Review.
-
Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.Am J Ther. 2016 May-Jun;23(3):e905-10. doi: 10.1097/MJT.0000000000000165. Am J Ther. 2016. PMID: 25828517 Review.
Cited by
-
Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults.J Hypertens. 2018 Jul;36(7):1548-1554. doi: 10.1097/HJH.0000000000001728. J Hypertens. 2018. PMID: 29570511 Free PMC article.
-
Investigating omega-3 fatty acids' neuroprotective effects in repetitive subconcussive neural injury: Study protocol for a randomized placebo-controlled trial.PLoS One. 2025 Apr 24;20(4):e0321808. doi: 10.1371/journal.pone.0321808. eCollection 2025. PLoS One. 2025. PMID: 40273177 Free PMC article.
-
Omega-3 mechanism of action in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the "Brazilian Omega Study" (BROS)-a randomized controlled trial.Trials. 2021 Dec 18;22(1):927. doi: 10.1186/s13063-021-05702-x. Trials. 2021. PMID: 34922604 Free PMC article.
-
Effects of Virgin Olive Oil on Blood Pressure and Renal Aminopeptidase Activities in Male Wistar Rats.Int J Mol Sci. 2021 May 20;22(10):5388. doi: 10.3390/ijms22105388. Int J Mol Sci. 2021. PMID: 34065436 Free PMC article.
-
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.Transl Psychiatry. 2013 Dec 17;3(12):e335. doi: 10.1038/tp.2013.110. Transl Psychiatry. 2013. PMID: 24346133 Free PMC article. Clinical Trial.
References
-
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572. - PubMed
-
- Lang CC, Gupta S, Kalra P, et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: Clinical evidence and pathophysiological mechanisms. Atherosclerosis. 2010;212:1–8. - PubMed
-
- Custodis F, Schirmer SH, Baumhakel M, Heusch G, Bohm M, Laufs U. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol. 2010;56:1973–1983. - PubMed
-
- Investigators G-P Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447–455. - PubMed
-
- Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet. 1989;2:757–761. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials